Earnings Pulse: Britannia, ABB India, Thermax, Jyothy Labs, Fine Organics, Birla Corp, Alkyl Amines, Bajaj Electricals – Q4 Results Unpacked

Unknown Apr 02, 2026 950 Views

India Inc’s Q4 earnings season delivered a mix of resilience, margin pressure, and strategic growth across major sectors. Here’s a concise roundup of the latest results for Britannia Industries, ABB India, Thermax, Jyothy Labs, Fine Organic Industries, Birla Corporation, Alkyl Amines,...

Key Highlights:

Britannia Industries: Q4 net profit rose 5.1% YoY to ₹557 crore, with revenue up 9.2% at ₹4,218.9 crore. Strategic pricing and rural expansion drove growth despite muted FMCG demand. The board recommended a ₹75/share dividend.
ABB India: Net sales grew 2.6% YoY to ₹3,159.6 crore; net profit rose 3.3% to ₹474.6 crore. EBITDA improved 3.4% to ₹674.6 crore, with a solid order backlog and steady cash position.
Thermax: Q4 net profit climbed 8–10% YoY to ₹206 crore on 11.6% higher revenue at ₹3,085 crore. The company declared a ₹14/share dividend. Margins narrowed slightly due to higher tech intervention costs, but the order book remains robust at ₹10,693 crore.
Jyothy Labs: Q4 net profit dipped 2.4% YoY to ₹76.3 crore, but revenue grew 1% to ₹667 crore. Volume growth was 4%, and EBITDA margin improved to 16.8%. Rural demand showed signs of recovery, but urban consumption stayed soft.
Fine Organic Industries: Q4 revenue rose 11% YoY to ₹607 crore, but net profit fell 15% to ₹97 crore. EBITDA margin contracted sharply to 19.7% amid cost pressures.
Birla Corporation: Q4 net profit surged 32.8% YoY to ₹256.6 crore, driven by strong cement volumes and improved realisations. The company declared a ₹10/share dividend and reduced net debt significantly.
Alkyl Amines: Q4 net profit jumped 18% YoY to ₹46 crore, revenue up 8% at ₹386 crore. EBITDA margin slipped to 17.6% due to operational cost increases. Final dividend of ₹10/share recommended.
Bajaj Electricals: Awaiting detailed Q4 results; previous quarters showed steady growth in consumer products and EPC segments.

Sources: Moneycontrol, Business Standard, India Infoline, Angel One, Economic Times, CNBC TV18, Business Upturn, Goodreturns, Groww, Univest, Energy Watch

Stay Ahead – Explore Now! Alembic Pharma Receives USFDA Tentative Approval for Larotrectinib